December 26, 2024
TOPLINE: Women with metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for cirrhosis, whereas men with MASLD have elevated risks for hepatocellular carcinoma, hepatic […]
December 26, 2024
TOPLINE: Women with metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for cirrhosis, whereas men with MASLD have elevated risks for hepatocellular carcinoma, hepatic […]
December 24, 2024
TOPLINE: Older adults with celiac disease (CeD) face a higher risk of developing frailty within 5 years than those without the condition, a finding that indicates […]
December 24, 2024
The scientific report that offers evidence-based guidance for the next iteration of the Dietary Guidelines for Americans has been submitted to federal agencies, and the document […]
December 19, 2024
International researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically with ulcerative colitis (UC) and Crohn’s disease (CD). Targeted droplet digital polymerase […]
December 18, 2024
Among patients with eosinophilic esophagitis (EoE), both those who are responsive to proton pump inhibitors (PPIs) and those who are unresponsive to PPI treatment share similar […]
December 18, 2024
For people with obesity or type 2 diabetes, glucagon-like peptide 1 (GLP-1) agonists (including Mounjaro, Wegovy, and Ozempic) have been labeled miracle drugs. But they aren’t […]
December 17, 2024
JERUSALEM (Reuters) -Israel’s Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and Crohn’s disease showed it had […]
December 17, 2024
There was a recent flurry of excitement when UK researchers from the Wellcome Sanger Institute, a nonprofit genomics and genetics research organization in Cambridge, England, announced […]